Literature DB >> 22172821

Impact of pre-existing left ventricular dysfunction on kidney transplantation outcomes: implications for patient selection.

V Karthikeyan1, J Chattahi, H Kanneh, J Koneru, S Hayek, A Patel, M Goggins, K Ananthasubramaniam.   

Abstract

BACKGROUND: End-stage kidney disease patients with decreased left ventricular ejection fraction (EF) are often denied kidney transplantation (KT) for fear of poor graft and patient survival.
METHODS: We retrospectively studied all patients who underwent KT at our center between 2001 and 2005 to determine the impact of low EF on outcomes post KT. Low EF was defined as <50% EF by noninvasive cardiac imaging. Follow-up was for 1 year post KT. Outcomes assessed included hospitalization for congestive heart failure (CHF), cardiac events, and renal allograft and patient survival.
RESULTS: Among 254 patients, 37 had low EF (study group) and 217 had normal EF (≥50%; control group). Post KT, the low EF group had a significantly higher rate of hospitalization for CHF. No significant difference was noted in the rate of cardiac events, graft loss, GFR, and all cause death at 12 months post KT.
CONCLUSION: Patients with low EF should not be excluded from transplantation, given favorable outcomes.
Copyright © 2011 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2011        PMID: 22172821     DOI: 10.1016/j.transproceed.2011.09.014

Source DB:  PubMed          Journal:  Transplant Proc        ISSN: 0041-1345            Impact factor:   1.066


  2 in total

1.  Myocardial remodeling after kidney transplantation: a case report.

Authors:  Marceli Lukaszewski; Kinga Kosiorowska; Dorota Kaminska; Marta Obremska; Oktawia Mazanowska; Magdalena Krajewska
Journal:  BMC Nephrol       Date:  2018-12-20       Impact factor: 2.388

Review 2.  Diagnosis and Management of Cardiovascular Disease in Advanced and End-Stage Renal Disease.

Authors:  Navdeep K Bhatti; Keyvan Karimi Galougahi; Yehuda Paz; Tamim Nazif; Jeffrey W Moses; Martin B Leon; Gregg W Stone; Ajay J Kirtane; Dimitri Karmpaliotis; Sabahat Bokhari; Mark A Hardy; Geoffrey Dube; Sumit Mohan; Lloyd E Ratner; David J Cohen; Ziad A Ali
Journal:  J Am Heart Assoc       Date:  2016-08-04       Impact factor: 5.501

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.